Literature DB >> 28390477

Current guidelines for the evaluation and management of atopic dermatitis: A comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology guidelines.

Lawrence F Eichenfield1, Jusleen Ahluwalia2, Andrea Waldman2, Jenna Borok2, Jeremy Udkoff2, Mark Boguniewicz3.   

Abstract

Atopic dermatitis (AD) is a chronic pruritic inflammatory disease that commonly presents in the pediatric population. Although definitions and diagnosis of AD have largely been agreed upon, allergists and dermatologists have similar and divergent approaches to the management of AD. This review facilitated integration of the American Academy of Allergy, Asthma & Immunology/American College of Allergy, Asthma & Immunology Joint Task Force 2012 AD Practice Parameter and the 2014 American Academy of Dermatology guidelines to highlight the basic principles of AD management and discuss therapies and management of AD from the distinct perspectives of the allergist and dermatologist.
Copyright © 2017 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  American Academy of Dermatology; Atopic dermatitis; Joint Task Force; eczema; guidelines; topical and systemic treatments

Mesh:

Substances:

Year:  2017        PMID: 28390477     DOI: 10.1016/j.jaci.2017.01.009

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  43 in total

Review 1.  Allergen Immunotherapy and Atopic Dermatitis: the Good, the Bad, and the Unknown.

Authors:  Patrick Rizk; Mario Rodenas; Anna De Benedetto
Journal:  Curr Allergy Asthma Rep       Date:  2019-11-27       Impact factor: 4.806

Review 2.  New and Potential Treatments for Atopic Dermatitis: Biologicals and Small Molecules.

Authors:  Mario Sánchez-Borges; Arnaldo Capriles-Hulett; Jose Antonio Ortega-Martell; Ignacio Ansotegui Zubeldia
Journal:  Curr Allergy Asthma Rep       Date:  2019-02-28       Impact factor: 4.806

3.  First-in-human topical microbiome transplantation with Roseomonas mucosa for atopic dermatitis.

Authors:  Ian A Myles; Noah J Earland; Erik D Anderson; Ian N Moore; Mark D Kieh; Kelli W Williams; Arhum Saleem; Natalia M Fontecilla; Pamela A Welch; Dirk A Darnell; Lisa A Barnhart; Ashleigh A Sun; Gulbu Uzel; Sandip K Datta
Journal:  JCI Insight       Date:  2018-05-03

4.  PAR2 Pepducin-Based Suppression of Inflammation and Itch in Atopic Dermatitis Models.

Authors:  Travis P Barr; Chris Garzia; Srijoy Guha; Elizabeth K Fletcher; Nga Nguyen; Adam J Wieschhaus; Lluis Ferrer; Lidija Covic; Athan Kuliopulos
Journal:  J Invest Dermatol       Date:  2018-10-01       Impact factor: 8.551

5.  Oral Intake of Lactobacillus helveticus NS8 Alleviates Ovalbumin-Induced Atopic Dermatitis in SKH-1 Hairless Mice.

Authors:  Jingjing Rong; Shuzhan Liu; Chao Hu; Feng Jin; Li Wang
Journal:  Indian J Microbiol       Date:  2018-04-11       Impact factor: 2.461

Review 6.  Dupilumab in atopic dermatitis: rationale, latest evidence and place in therapy.

Authors:  Lieneke F M Ariëns; Daphne S Bakker; Jorien van der Schaft; Floor M Garritsen; Judith L Thijs; Marjolein S de Bruin-Weller
Journal:  Ther Adv Chronic Dis       Date:  2018-05-11       Impact factor: 5.091

7.  Systematic Review and Meta-analysis Comparing Topical Corticosteroids With Vehicle/Moisturizer in Childhood Atopic Dermatitis.

Authors:  Anna B Fishbein; Kelly Mueller; Jennifer Lor; Patricia Smith; Amy S Paller; Aaron Kaat
Journal:  J Pediatr Nurs       Date:  2019-04-23       Impact factor: 2.145

8.  Lipid abnormalities in atopic skin are driven by type 2 cytokines.

Authors:  Evgeny Berdyshev; Elena Goleva; Irina Bronova; Nathan Dyjack; Cydney Rios; John Jung; Patricia Taylor; Mingeum Jeong; Clifton F Hall; Brittany N Richers; Kathryn A Norquest; Tao Zheng; Max A Seibold; Donald Ym Leung
Journal:  JCI Insight       Date:  2018-02-22

Review 9.  The Challenge of Managing Atopic Dermatitis in the United States.

Authors:  Steven R Feldman; Linda S Cox; Lindsay C Strowd; Robert A Gerber; Steven Faulkner; Debra Sierka; Timothy W Smith; Joseph C Cappelleri; Mark E Levenberg
Journal:  Am Health Drug Benefits       Date:  2019-04

Review 10.  Clinical approach to the patient with refractory atopic dermatitis.

Authors:  Neema Izadi; Donald Y M Leung
Journal:  Ann Allergy Asthma Immunol       Date:  2018-01       Impact factor: 6.347

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.